The role of outer membrane and efflux pumps in the resistance of gram-negative bacteria. Can we improve drug access?

Drug Resistance Updates

Volumn 1, Issue 2, 1998, Pages 93-98

  Nikaido, Hiroshi ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0002554841     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80023-X     Document Type: Review

References (45)

1. Vaara M. Antibiotic-supersusceptible mutants of Escherichia coli and Salmonella typhimurium. Antimicrob Agents Chemother 37 (1993) 2255-2260
2. Nikaido H. Multidrug efflux pumps of gram-negative bacteria. J Bacteriol 178 (1996) 5853-5859
3. Nikaido H., and Vaara M. Molecular basis of bacterial outer membrane permeability. Microbiol Rev 49 (1985) 1-32
4. Cowan S.W., Schirmer T., Rummel G., et al. Crystal structures explain functional properties of two E. coli porins. Nature 358 (1992) 727-733
5. Nikaido H., Nikaido K., and Harayama S. Identification and characterization of porins in Pseudomonas aeruginosa. J Biol Chem 266 (1991) 770-779
6. Plésiat P., and Nikaido H. Outer membranes of gram-negative bacteria are permeable to steroid probes. Mol Microbiol 6 (1992) 1323-1333
7. Nikaido H. Outer membrane barrier as a mechanism of antimicrobial resistance. Antimicrob Agents Chemother 33 (1989) 1831-1836
8. Nikaido H., and Normark S. Sensitivity of Escherichia coli to various β-lactams is determined by the interplay of outer membrane permeability and degradation by periplasmic β-lactamases: a quantitative predictive treatment. Mol Microbiol 1 (1987) 29-36
9. Paulsen I.T., Brown M.H., and Skurray R.A. Proton-dependent multidrug efflux systems. Microbiol Rev 60 (1996) 575-608
10. Williams R.J., Livermore D.M., Lindridge M.A., Said A.A., and Williams J.D. Mechanisms of beta-lactam resistance in British isolates of Pseudomonas aeruginosa. J Med Microbiol 17 (1984) 283-293
11. Li X.Z., Nikaido H., and Poole K. Role of MexA-MexB-OprM in antibiotic efflux in Pseudomonas aeruginosa. Antimicrob Agents Chemother 39 (1995) 1948-1953
12. Köhler T., Kok M., Michea-Hamzehpour M., et al. Multidrug efflux in intrinsic resistance to trimethoprim and sulfamethoxazole in Pseudomonas aeruginosa. Antimicrob Agents Chemother 40 (1996) 2288-2290
13. Ma D., Cook D.N., Alberti M., et al. Genes acrA and acrB encode a stress-induced efflux system of Escherichia coli. Mol Microbiol 16 (1995) 46-55
14. Alekshun M.N., and Levy S.B. Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon. Antimicrob Agents Chemother 41 (1997) 2067-2075
15. Angus BL, Carey AM, Caron DA, Kropinski AMB, Hancock REW. Outer membrane permeability in Pseudomonas aeruginosa: comparison of a wild-type with an antibiotic-supersusceptible mutant. Antimicrob Agents Chemother 21: 299-309.
16. Yoshimura F., and Nikaido H. Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes. J Bacteriol 152 (1992) 636-642
17. Köhler T., Michea-Hamzehpour M., Henze U., et al. Characterization of MexE-MexF-OprN, a positively regulated multidrug efflux system of Pseudomonas aeruginosa. Mol Microbiol 23 (1997) 345-354
18. Abstracts,. Buysse J.M., Demyan W.F., Dunyak D.S., et al. Mutation of the AcrAB antibiotic efflux pump in Escherichia coli confers susceptibility to oxazolidinone antibiotics. 36th Interscience Conference on Antimicrobial Agents and Chemotherapy (1996)
19. Nelson M.L., Park B.H., Andrews J.S., et al. Inhibition of the tetracycline efflux antiport protein by 13-thio-substituted 5-hydroxy-6-deoxytetracyclines. J Med Chem 36 (1993) 370-377
20. Neyfakh A.A., Bidnenko V.E., and Chen L.B. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc Natl Acad Sci USA 88 (1991) 4781-4785
21. Jacob M.I. Drug-resistant bacteria pose threat to progress in infectious disease reduction. Genet Eng News 17 2 (1997) 6
22. Sugawara E., and Nikaido H. OmpA protein of Escherichia coli outer membrane occurs in open and closed channel forms. J Biol Chem 269 (1994) 17981-17987
23. Woodruff W.A., Parr Jr. T.R., and Hancock R. Expression in Escherichia coli and function of Pseudomonas aeruginosa outer membrane porin protein F. J Bacteriol 167 (1986) 473-479
24. Bellido F., Martin N.L., Siehnel R.J., and Hancock R. Reevaluation, using intact cells, of the exclusion limit and role of porin OprF in Pseudomonas aeruginosa outer membrane permeability. J Bacteriol 174 (1992) 5196-5203
25. Plésiat P., Aires J.R., Godard C., and Köhler T. Use of steroids to monitor alterations in the outer membrane of Pseudomonas aeruginosa. J Bacteriol 179 (1997) 7004-7010
26. Vaara M. Agents that increase the permeability of the outer membrane. Microbiol Rev 56 (1992) 395-411
27. Vaara M., and Vaara T. Sensitization of gram-negative bacteria to antibiotics and complement by a nontoxic oligopeptide. Nature 303 (1983) 526-528
28. Vilianen P., and Vaara M. Susceptibility of gram-negative bacteria to polymyxin B nonapeptide. Antimicrob Agents Chemother 25 (1984) 701-705
29. Kitahara T., Yoneyama H., and Nakae T. Antibiotic diffusion pathways in the outer membrane of Pseudomonas aeruginosa. Biochem Biophys Res Commun 238 (1997) 457-461
30. Hancock R., Falla T., and Brown M. Cationic bactericidal peptides. Adv Microb Physiol 37 (1995) 135-175
31. Robinson R.A., and Stokes R.H. Electrolyte Solutions (1955), Academic Press
32. Selsted M.E., Szklarek D., and Lehrer R.I. Purification and antibacterial activity of antimicrobial peptides of rabbit granulocytes. Inf Immun 45 (1984) 150-154
33. Viljanen P., Koski P., and Vaara M. Effect of small cationic leukocyte peptides (defensins) on the permeability barrier of the outer membrane. Inf Immum 56 (1988) 2324-2329
34. Lehrer R.I., Lichtenstein A.K., and Ganz T. Defensins: antimicrobial and cytotoxic peptides of mammalian cells. Annu Rev Immunol (1993) 105-128
35. Lehrer R.I., Ganz T., and Selsted M.E. Defensins: endogenous antibiotic peptides of animal cells. Cell 64 (1991) 229-230
36. 2+ environments. J Bacteriol 179 (1997) 7040-7045
37. Hultmark D., Engström A., and Bennich H. Eur J Biochem 127 (1982) 207-217
38. Lee I.H., Cho Y., and Lehrer R.I. Effects of pH and salinity on the antimicrobial properties of clavanins. Inf Immun 65 (1997) 2898-2903
39. Vaara M., and Porro M. Group of peptides that act synergistically with hydrophobic antibiotics against gram-negative enteric bacteria. Antimicrob Agents Chemother 40 (1996) 1801-1805
40. Gough M., Hancock R., and Kelly N.M. Antiendotoxin activity of cationic peptide antimicrobial agents. Infect Immun 64 (1996) 4922-4927
41. Piers K., Brown M.H., and Hancock R. Recombinant DNA procedures for producing small antimicrobial cationic peptides in bacteria. Gene 134 (1993) 7-13
42. Mannion B.A., Kalatzis E.S., Weiss J., and Elsbach P. Preferential binding of the neutrophil cytoplasmic granule-derived bactericidal/permeability increasing protein to target bacteria. J Immunol 142 (1989) 2807-2812
43. Saier MH Jr, Paulsen IT, Sliwinski MK et al. Evolutionary origins of multidrug and drug-specific efflux pumps in bacteria. FASEB J, in press.
44. Ahmed M., Borsch C.M., Neyfakh A.A., and Schuldiner S. Mutants of the Bacillus subtilis multidrug transporter Bmr with altered sensitivity to the antihypertensive alkaloid reserpine. J Biol Chem 268 (1993) 11086-11089
45. Bert F., and Lambert-Zechovsky N. Comparative distribution of resistance patterns and serotypes in Pseudomonas aeruginosa isolates from intensive care units and other wards. J Antimicrob Chemother 37 (1996) 809-813